Evidence map›Paper›PMID 42131636›Full record

ArticleCureus2026

Transcatheter Embolotherapy of Maternal Pulmonary Arteriovenous Malformation During Twin Pregnancy With Hereditary Hemorrhagic Telangiectasia: A Case Report.

Akiko Takashima, Tomomi Komiyama, Megumi Manrai, Shusuke Kasuya, Hitoshi Terada

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Akiko TakashimaObsterics and Gynecology, Toho University Sakura Medical Center, Sakura, JPN.
Tomomi KomiyamaObstetrics and Gynecology, Toho University Sakura Medical Center, Sakura, JPN.
Megumi ManraiOncology, Toho University Sakura Medical Center, Sakura, JPN.
Shusuke KasuyaRadiology, Toho University Sakura Medical Center, Sakura, JPN.
Hitoshi TeradaRadiology, Toho University Sakura Medical Center, Sakura, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hereditary hemorrhagic telangiectasia (HHT) is a multiple-organ disease. Herein, we report a case of rupture of an undiagnosed pulmonary arteriovenous malformation (PAVM) during pregnancy in which good outcomes for both mother and children were achieved with transcatheter embolization. The patient was a pregnant 32-year-old Pashtun woman, G4P3, with a history of cesarean section. She had undergone pregnancy checkups at our hospital for a dichorionic diamniotic twin pregnancy. In gestational week 20, the patient experienced loss of consciousness at home and was transported by ambulance to our hospital. Her Glasgow Coma Scale score was 9 (E2V2M5) and her blood pressure was 57/27 mmHg. Blood test results showed severe anemia; right atelectasis and mediastinal shift were shown on chest radiography. Contrast-enhanced chest computed tomography revealed right hemothorax and a single pulmonary arteriovenous malformation measuring 35 mm in the middle lobe of the right lung. The patient was diagnosed with hemothorax due to rupture of the right PAVM. Emergency transcatheter embolization was performed, disappearance of the arteriovenous malformation was confirmed, and hemostasis was achieved. Recurrent epistaxis and telangiectasias on the tongue, buccal mucosa, and nasal cavity were noted, and the patient was diagnosed with HHT. An abdominal cesarean section was performed due to the low-lying placenta and right hydronephrosis. Two male neonates were delivered: one weighed 1988 g and the other 2166 g. Both mother and infants progressed well. This case illustrates how unrecognized HHT can lead to catastrophic PAVM rupture during pregnancy and emphasizes the lifesaving value of early diagnosis and prompt endovascular intervention. In addition, it highlights the critical importance of pre‑pregnancy screening for HHT to prevent life‑threatening complications.

Indexed as

hereditary hemorrhagic telangiectasia (hht)high-risk pregnancypulmonary arteriovenous malformationsspontaneous rupturetranscatheter embolotherapy

Identifiers

PMID42131636
PMCPMC13167206

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.